IRBESARTAN AND HYDROCHLOROTHIAZIDE (Hisun Pharmaceuticals USA Inc.)
Welcome to the PulseAid listing for the IRBESARTAN AND HYDROCHLOROTHIAZIDE drug offered from Hisun Pharmaceuticals USA Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hisun Pharmaceuticals USA Inc. |
| NON-PROPRIETARY NAME: | irbesartan and hydrochlorothiazide |
| SUBSTANCE NAME: | IRBESARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-10-14 |
| END MARKETING DATE: | 0000-00-00 |
IRBESARTAN AND HYDROCHLOROTHIAZIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | IRBESARTAN AND HYDROCHLOROTHIAZIDE from Hisun Pharmaceuticals USA Inc. |
| LABELER NAME: | Hisun Pharmaceuticals USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-10-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42658-141_3f08eeda-dbc2-0db5-e054-00144ff88e88 |
| PRODUCT NDC: | 42658-141 |
| APPLICATION NUMBER: | ANDA207896 |
Other IRBESARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
